4P-Pharma secures a total capital of EUR 15Mln in second closing
4P-Pharma, a Lille-based clinical-stage startup studio focused on developing curative therapies for untreated serious diseases, announces that it has successfully secured a total capital of €15 million in its second closing with participation from private investors. With this funding, 4P-Pharma’s shareholders renew their confidence in the company’s drug regeneration model for untreated serious diseases. They […]
SVB Financial Group announces appointment of restructuring committee
SVB Financial Group announced yesterday that its Board of Directors has appointed a restructuring committee consisting of five independent directors to explore strategic alternatives for the holding company and its SVB Capital and SVB Securities businesses, as well as its other assets and investments. Both of these businesses are separate divisions of SVBFG and not […]
